Clinical Trials Logo

Cardiovascular clinical trials

View clinical trials related to Cardiovascular.

Filter by:

NCT ID: NCT03277183 Terminated - Anemia Clinical Trials

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

Start date: November 2, 2017
Phase: Phase 4
Study type: Interventional

Although several large well designed clinical trials have shown that erythropoietin which is commonly used to treat anemia associated with kidney disease, increases the risk of stroke and heart disease, the mechanism for this increased risk is unknown. The investigators' preliminary studies show that the adverse effects of erythropoietin are from activation of the heterodimeric erythropoietin/ beta common receptor which only occurs with high doses of erythropoietin. The investigators propose a clinical trial of 120 patients assigned to low doses of erythropoietin given more frequently or the same cumulative dose of erythropoietin administered as a high dose once every two weeks and assess effects on the beta common receptor activation, inflammation and vascular disease as evidence by MRI of the carotid arteries.

NCT ID: NCT03236363 Completed - Obesity Clinical Trials

Effectiveness of MOVI Interventions on Adiposity, Cognition and Motor Competence: MOVI-da10!

MOVI-da10!
Start date: September 19, 2017
Phase: N/A
Study type: Interventional

Project which objective is to test the effectiveness of a classroom-based physical activity intervention (MOVI-da10!) on improving, body composition, cardio-respiratory fitness and executive function.

NCT ID: NCT03236337 Completed - Obesity Clinical Trials

Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit!

Start date: September 19, 2017
Phase: N/A
Study type: Interventional

Project which objective is to test the effectiveness of an extracurricular physical activity intervention based on high intensity interval training (MOVI-daFit!) on improving cardiorespiratory fitness (CRF), cardiometabolic risk, executive function, and academic performance.

NCT ID: NCT03203863 Completed - Children Clinical Trials

Metabolic Syndrome in Children and Adolescents

Start date: April 1, 2009
Phase: N/A
Study type: Observational

The purpose of this study was to cross-sectionally evaluate nutritional status and the metabolic syndrome in a sample of school-age children 10-15 years of age from 20 public schools in Santiago, Chile. In addition, the investigators retrospectively assessed the association of those variables with perinatal variables (birth weight, birth length, and gestational age at delivery).

NCT ID: NCT03170193 Completed - Cardiovascular Clinical Trials

AMG 529 First in Human Study

Start date: May 15, 2017
Phase: Phase 1
Study type: Interventional

A study to assess the safety and tolerability of AMG 529 following single, ascending doses administered subcutaneously (SC) or intravenously (IV) in healthy adults.

NCT ID: NCT01820598 Recruiting - Obesity Clinical Trials

Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients

StimobII
Start date: January 2013
Phase: N/A
Study type: Interventional

The study was designed to test the following hypotheses: In patients with severe obesity, a multisite electrostimulation session (m-NMES) will induce higher changes in metabolic, inflammatory and cardiovascular parameters and higher increase in muscle strength during stimulated contractions than conventional unidirectional electrostimulation session (c-NMES). In patients with severe obesity, a six-weeks m-NMES training program will enhance cardiovascular, metabolic and inflammatory parameters.

NCT ID: NCT01489696 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

Start date: August 2010
Phase: Phase 1
Study type: Interventional

The study aims to compare blood pressure and pulse in male healthy subjects taking mirabegron and tamsulosin both alone and in combination.

NCT ID: NCT01304641 Completed - Dyslipidemia Clinical Trials

Cardiovascular Events Based On Statin Initiation In The Elderly

Start date: November 2009
Phase:
Study type: Observational

The purpose of this study is to compare rates and risk of primary cardiovascular events among elderly patients newly initiating therapy with atorvastatin or simvastatin. The specific objectives for this project are to: 1) examine the demographic and clinical characteristics of the elderly patients in whom atorvastatin or simvastatin was newly initiated; and 2) compare cardiovascular event rates in elderly patients in whom atorvastatin or simvastatin was newly initiated.

NCT ID: NCT01232309 Completed - Cardiovascular Clinical Trials

Effects of Chitin-Glucan on Oxidized Low-Density Lipoprotein (LDL)

Start date: August 2010
Phase: N/A
Study type: Interventional

Cardiovascular diseases (CVDs), especially atherosclerotic coronary heart disease and stroke, are the leading causes of death globally. Important risk factors for CVDs include elevated serum levels of total cholesterol, low-density lipoprotein(LDL)-cholesterol, triglycerides, and low high-density lipoprotein (HDL)-cholesterol. Elevated "oxidized" LDL, a pro-inflammatory villain, has also emerged as an important risk factor for the development of CVDs. There is a growing need to identify safe and effective nutritional interventions that offer a clinical benefit aimed at reducing one more of the risk factors for CVDs. Data from many studies in humans have shown various health benefits provided by dietary fiber intake, including an inverse association with the risk of developing cardiovascular disease. The primary purpose of this study is to determine whether daily consumption for 6 weeks of chitin-glucan, a fiber purified from a microorganism, is effective at reducing the amount of oxidized LDL in humans with borderline-to-high LDL-cholesterol. The effects of chitin-glucan on other cardiovascular risk factors will also be evaluated.

NCT ID: NCT00954902 Completed - Clinical trials for Psychological Stress

Effects of Antioxidants on Cardiovascular Risk Measures (Spice Study)

Spice
Start date: August 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether feeding highly antioxidant spices of providing these same antioxidants as capsules is able to affect cardiovascular risk measures. Because this is a new area of research, the investigators will use many measures to assess this question including blood markers, tests of blood vessel health, measures of blood pressure responses, measures of clotting activity, and other inflammation measures.